Repligen (RGEN) Operating Income (2010 - 2026)

Repligen (RGEN) has 17 years of Operating Income data on file, last reported at $15.9 million in Q1 2026.

• Operating Income for Q1 2026 came in at $15.9 million, up 142.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $64.5 million (up 2364.97% YoY), and the FY2025 annual result was $55.2 million, up 1071.76% from the prior year.
• Operating Income fell to $15.9 million in Q1 2026 per RGEN's latest filing, from $17.9 million in the prior quarter.
• Over five years, Operating Income peaked at $63.2 million in Q2 2022 and troughed at -$25.9 million in Q4 2023.
• A 5-year average of $17.8 million and a median of $13.9 million in 2025 frame the typical range for Operating Income.
• The sharpest annual moves came in 2024 and 2025: Operating Income plunged 266.96% in 2024, then jumped 352.94% in 2025.
• A 5-year view of Operating Income shows it stood at $48.8 million in 2022, then tumbled by 153.07% to -$25.9 million in 2023, then surged by 72.75% to -$7.1 million in 2024, then jumped by 352.94% to $17.9 million in 2025, then slipped by 10.79% to $15.9 million in 2026.
• Business Quant data shows RGEN's Operating Income at $15.9 million in Q1 2026, $17.9 million in Q4 2025, and $16.8 million in Q3 2025.